Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cereno Scientific ABFRA:4A1 +4.69%39 Buyback Yield % is -0.33 as of Aug. 02, 2026. GuruFocus rates FRA:4A1 with a GF Score™ of 39/100. The stock has 3 warning signs investors should review. Among 279 Drug Manufacturers companies, Cereno Scientific AB ranks better than 53.41% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Cereno Scientific AB Buyback Yield % Related Terms
Cereno Scientific AB Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Cereno Scientific AB's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cereno Scientific AB Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Cereno Scientific AB's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cereno Scientific AB (FRA:4A1) has a Buyback Yield % of -0.33 as of Aug. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cereno Scientific AB and its competitors. According to the industry distribution chart, Cereno Scientific AB ranks #130 out of 279 companies in the Drug Manufacturers industry, placing it in the top 46.6%.
Is Cereno Scientific AB's Buyback Yield % too high?
Cereno Scientific AB's current Buyback Yield % is -0.33. Based on the distribution chart, Cereno Scientific AB ranks #130 out of 279 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Cereno Scientific AB has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Cereno Scientific AB's Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Cereno Scientific AB ranks #130 out of 279 companies for Buyback Yield %. This puts Cereno Scientific AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cereno Scientific AB and its competitors. Cereno Scientific AB's current Buyback Yield % is -0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cereno Scientific AB stock overvalued right now?
Cereno Scientific AB (FRA:4A1) has a current Buyback Yield % of -0.33. The current Buyback Yield % is -0.33. Cereno Scientific AB's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cereno Scientific AB (FRA:4A1), the current Buyback Yield % is -0.33 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. It also evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.
39GF Score
Get the complete analysis for FRA:4A1
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4A1 has been successfully added to your 
